Dallah Healthcare Co. reported a net profit of SAR 147.7 million in H1 2023, a decline of 3% from SAR 152.1 million a year earlier.
Item | 6m 2022 | 6m 2023 | Change |
---|---|---|---|
Revenues | 1,193.22 | 1,387.06 | 16.2 % |
Gross Income | 443.83 | 501.87 | 13.1 % |
Operating Income | 206.60 | 220.35 | 6.7 % |
Net Income | 152.15 | 147.67 | (2.9 %) |
Average Shares | 90.00 | 97.68 | 8.5 % |
EPS (Riyals) | 1.69 | 1.51 | (10.6 %) |
The decline was attributed to Murabaha costs, which increased by SAR 32 million on higher finance costs. Accordingly, the net profit attributable to shareholders decreased.
By contrast, Dallah Healthcare reported an increase of SAR 10 million year-on-year (YoY) in the results of associates. Revenues for the six-month period jumped 16% YoY to SAR 1.38 billion. Operating profit also rose 12% YoY to SAR 241 million in H1 2023.
The second-quarter net profit fell by 24% to SAR 53 million from SAR 69.5 million in Q2 2022, due to higher finance costs and Zakat provisions despite better revenue on an annual basis. Operating profit also grew by 2% YoY to SAR 103 million.
The net profit also dipped 44% from SAR 94.66 million in Q1 2023 as revenues decreased by 6.5% to SAR 670 million on seasonal factors
Item | Q2 2022 | Q2 2023 | Change |
---|---|---|---|
Revenues | 583.82 | 670.42 | 14.8 % |
Gross Income | 212.13 | 235.08 | 10.8 % |
Operating Income | 96.68 | 87.85 | (9.1 %) |
Net Income | 69.52 | 53.01 | (23.8 %) |
Average Shares | 90.00 | 97.68 | 8.5 % |
EPS (Riyals) | 0.77 | 0.54 | (29.8 %) |
Item | Q1 2023 | Q2 2023 | Change |
---|---|---|---|
Revenues | 716.64 | 670.42 | (6.5 %) |
Gross Income | 266.79 | 235.08 | (11.9 %) |
Operating Income | 132.49 | 87.85 | (33.7 %) |
Net Income | 94.66 | 53.01 | (44.0 %) |
Average Shares | 97.68 | 97.68 | - |
EPS (Riyals) | 0.97 | 0.54 | (44.0 %) |
Shareholders’ equity, after minority interest, rose to SAR 3.13 billion as of June 30, 2023, from SAR 2.02 billion a year earlier.
Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
---|---|---|---|---|---|---|
Q1 2014 | 207.57 | 13.0 % | 87.60 | 3.8 % | 39.73 | 3.5 % |
Q2 2014 | 219.45 | 16.9 % | 93.78 | 16.2 % | 33.46 | 10.8 % |
Q3 2014 | 192.79 | 15.4 % | 75.36 | 13.0 % | 21.67 | (1.3 %) |
Q4 2014 | 240.08 | 13.8 % | 103.54 | 8.2 % | 50.24 | 4.5 % |
2014 | 858.75 | 14.6 % | 358.57 | 9.5 % | 145.09 | 5.5 % |
Q1 2015 | 240.40 | 15.8 % | 102.13 | 16.6 % | 39.67 | (0.1 %) |
Q2 2015 | 245.23 | 11.7 % | 100.89 | 7.6 % | 35.71 | 6.7 % |
Q3 2015 | 223.93 | 16.2 % | 87.92 | 16.7 % | 26.37 | 21.7 % |
Q4 2015 | 276.50 | 15.2 % | 116.81 | 12.8 % | 57.01 | 13.5 % |
2015 | 985.44 | 14.8 % | 407.14 | 13.5 % | 160.78 | 10.8 % |
Q1 2016 | 285.03 | 18.6 % | 132.53 | 29.8 % | 61.90 | 56.1 % |
Q2 2016 | 288.35 | 17.6 % | 129.78 | 28.6 % | 59.34 | 66.2 % |
Q3 2016 | 273.17 | 22.0 % | 122.38 | 39.2 % | 51.80 | 96.4 % |
Q4 2016 | 316.24 | 14.4 % | 151.01 | 29.3 % | 57.96 | 1.7 % |
2016 | 1,162.79 | 18.0 % | 535.70 | 31.6 % | 231.00 | 43.7 % |
Q1 2017 | 302.75 | 6.2 % | 143.60 | 8.4 % | 85.82 | 38.6 % |
Q2 2017 | 288.20 | 0.0 % | 130.48 | 0.5 % | 70.86 | 19.4 % |
Q3 2017 | 295.25 | 8.1 % | 136.77 | 11.8 % | 76.36 | 47.4 % |
Q4 2017 | 325.87 | 3.0 % | 148.23 | (1.8 %) | 74.95 | 29.3 % |
2017 | 1,212.08 | 4.2 % | 559.08 | 4.4 % | 307.98 | 33.3 % |
Q1 2018 | 308.59 | 1.9 % | 131.73 | (8.3 %) | 59.44 | (30.7 %) |
Q2 2018 | 273.13 | (5.2 %) | 92.38 | (29.2 %) | 19.67 | (72.2 %) |
Q3 2018 | 280.94 | (4.8 %) | 101.37 | (25.9 %) | 33.44 | (56.2 %) |
Q4 2018 | 318.28 | (2.3 %) | 110.86 | (25.2 %) | 33.04 | (55.9 %) |
2018 | 1,180.94 | (2.6 %) | 436.34 | (22.0 %) | 145.59 | (52.7 %) |
Q1 2019 | 321.15 | 4.1 % | 120.26 | (8.7 %) | 41.24 | (30.6 %) |
Q2 2019 | 286.00 | 4.7 % | 92.46 | 0.1 % | 18.06 | (8.2 %) |
Q3 2019 | 301.34 | 7.3 % | 107.78 | 6.3 % | 30.99 | (7.3 %) |
Q4 2019 | 343.60 | 8.0 % | 127.34 | 14.9 % | 64.09 | 94.0 % |
2019 | 1,252.09 | 6.0 % | 447.85 | 2.6 % | 154.39 | 6.0 % |
Q1 2020 | 314.61 | (2.0 %) | 105.76 | (12.1 %) | 26.42 | (35.9 %) |
Q2 2020 | 247.56 | (13.4 %) | 67.77 | (26.7 %) | 7.97 | (55.9 %) |
Q3 2020 | 350.79 | 16.4 % | 132.62 | 23.0 % | 50.51 | 63.0 % |
Q4 2020 | 405.30 | 18.0 % | 143.57 | 12.7 % | 40.26 | (37.2 %) |
2020 | 1,318.25 | 5.3 % | 449.73 | 0.4 % | 125.16 | (18.9 %) |
Q1 2021 | 494.67 | 57.2 % | 176.82 | 67.2 % | 72.91 | 176.0 % |
Q2 2021 | 490.83 | 98.3 % | 168.17 | 148.1 % | 68.57 | 760.1 % |
Q3 2021 | 544.12 | 55.1 % | 192.46 | 45.1 % | 69.95 | 38.5 % |
Q4 2021 | 575.57 | 42.0 % | 222.91 | 55.3 % | 116.48 | 189.4 % |
2021 | 2,105.18 | 59.7 % | 760.36 | 69.1 % | 327.92 | 162.0 % |
Q1 2022 | 609.40 | 23.2 % | 231.69 | 31.0 % | 109.93 | 50.8 % |
Q2 2022 | 583.82 | 18.9 % | 212.13 | 26.1 % | 96.68 | 41.0 % |
Q3 2022 | 600.89 | 10.4 % | 211.47 | 9.9 % | 84.19 | 20.4 % |
Q4 2022 | 693.88 | 20.6 % | 239.81 | 7.6 % | 101.69 | (12.7 %) |
2022 | 2,487.98 | 18.2 % | 895.10 | 17.7 % | 392.49 | 19.7 % |
Q1 2023 | 716.64 | 17.6 % | 266.79 | 15.1 % | 132.49 | 20.5 % |
Q2 2023 | 670.42 | 14.8 % | 235.08 | 10.8 % | 87.85 | (9.1 %) |
Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
---|---|---|---|---|---|---|
2013 | 749.65 | 17.7 % | 327.45 | 14.1 % | 137.53 | 5.2 % |
2014 | 858.75 | 14.6 % | 358.57 | 9.5 % | 145.09 | 5.5 % |
2015 | 985.44 | 14.8 % | 407.14 | 13.5 % | 160.78 | 10.8 % |
2016 | 1,162.79 | 18.0 % | 535.70 | 31.6 % | 231.00 | 43.7 % |
2017 | 1,212.08 | 4.2 % | 559.08 | 4.4 % | 307.98 | 33.3 % |
2018 | 1,180.94 | (2.6 %) | 436.34 | (22.0 %) | 145.59 | (52.7 %) |
2019 | 1,252.09 | 6.0 % | 447.85 | 2.6 % | 154.39 | 6.0 % |
2020 | 1,318.25 | 5.3 % | 449.73 | 0.4 % | 125.16 | (18.9 %) |
2021 | 2,105.18 | 59.7 % | 760.36 | 69.1 % | 327.92 | 162.0 % |
2022 | 2,487.98 | 18.2 % | 895.10 | 17.7 % | 392.49 | 19.7 % |
Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS Before XO Items |
---|---|---|---|---|---|---|
Q1 2014 | 40.50 | 3.7 % | 0.45 | - | 40.50 | 0.45 |
Q2 2014 | 34.33 | 45.2 % | 0.38 | - | 34.33 | 0.38 |
Q3 2014 | 21.94 | 0.5 % | 0.24 | - | 21.94 | 0.24 |
Q4 2014 | 50.35 | (3.4 %) | 0.56 | - | 50.35 | 0.56 |
2014 | 147.12 | 7.7 % | 1.63 | - | 147.12 | 1.63 |
Q1 2015 | 47.82 | 18.1 % | 0.53 | 13.75 | 34.07 | 0.38 |
Q2 2015 | 35.86 | 4.4 % | 0.40 | - | 35.86 | 0.40 |
Q3 2015 | 26.78 | 22.1 % | 0.30 | - | 26.78 | 0.30 |
Q4 2015 | 54.60 | 8.4 % | 0.61 | - | 54.60 | 0.61 |
2015 | 165.06 | 12.2 % | 1.83 | 13.75 | 151.31 | 1.68 |
Q1 2016 | 58.07 | 21.4 % | 0.65 | (2.02) | 60.09 | 0.67 |
Q2 2016 | 54.14 | 51.0 % | 0.60 | (3.07) | 57.21 | 0.64 |
Q3 2016 | 60.80 | 127.0 % | 0.68 | 9.42 | 51.39 | 0.57 |
Q4 2016 | 51.71 | (5.3 %) | 0.57 | (6.00) | 57.71 | 0.64 |
2016 | 224.71 | 36.1 % | 2.50 | (1.68) | 226.39 | 2.52 |
Q1 2017 | 85.05 | 46.5 % | 0.94 | - | 85.05 | 0.94 |
Q2 2017 | 69.99 | 29.3 % | 0.78 | - | 69.99 | 0.78 |
Q3 2017 | 76.82 | 26.3 % | 0.85 | - | 76.82 | 0.85 |
Q4 2017 | 63.12 | 22.1 % | 0.70 | (11.69) | 74.81 | 0.83 |
2017 | 294.98 | 31.3 % | 3.28 | (11.69) | 306.67 | 3.41 |
Q1 2018 | 58.09 | (31.7 %) | 0.65 | - | 58.09 | 0.65 |
Q2 2018 | 18.73 | (73.2 %) | 0.21 | - | 18.73 | 0.21 |
Q3 2018 | 32.48 | (57.7 %) | 0.36 | - | 32.48 | 0.36 |
Q4 2018 | 32.47 | (48.6 %) | 0.36 | - | 32.47 | 0.36 |
2018 | 141.76 | (51.9 %) | 1.58 | - | 141.76 | 1.58 |
Q1 2019 | 35.17 | (39.5 %) | 0.39 | - | 35.17 | 0.39 |
Q2 2019 | 15.35 | (18.1 %) | 0.17 | - | 15.35 | 0.17 |
Q3 2019 | 26.62 | (18.1 %) | 0.30 | - | 26.62 | 0.30 |
Q4 2019 | 69.79 | 115.0 % | 0.78 | 13.39 | 56.41 | 0.63 |
2019 | 146.92 | 3.6 % | 1.63 | 13.39 | 133.53 | 1.48 |
Q1 2020 | 19.24 | (45.3 %) | 0.21 | - | 19.24 | 0.21 |
Q2 2020 | 6.99 | (54.4 %) | 0.08 | - | 6.99 | 0.08 |
Q3 2020 | 53.78 | 102.1 % | 0.60 | 16.36 | 37.42 | 0.42 |
Q4 2020 | 51.98 | (25.5 %) | 0.58 | 34.87 | 17.11 | 0.19 |
2020 | 132.00 | (10.2 %) | 1.47 | 51.23 | 80.76 | 0.90 |
Q1 2021 | 52.61 | 173.4 % | 0.58 | - | 52.61 | 0.58 |
Q2 2021 | 47.54 | 579.9 % | 0.53 | - | 47.54 | 0.53 |
Q3 2021 | 49.85 | (7.3 %) | 0.55 | - | 49.85 | 0.55 |
Q4 2021 | 108.60 | 108.9 % | 1.21 | 10.35 | 98.25 | 1.09 |
2021 | 258.60 | 95.9 % | 2.87 | 10.35 | 248.26 | 2.76 |
Q1 2022 | 82.63 | 57.1 % | 0.92 | - | 82.63 | 0.92 |
Q2 2022 | 69.52 | 46.2 % | 0.77 | - | 69.52 | 0.77 |
Q3 2022 | 43.87 | (12.0 %) | 0.49 | - | 43.87 | 0.49 |
Q4 2022 | 78.44 | (27.8 %) | 0.87 | - | 78.44 | 0.87 |
2022 | 274.46 | 6.1 % | 3.05 | - | 274.46 | 3.05 |
Q1 2023 | 94.66 | 14.6 % | 0.97 | - | 94.66 | 0.97 |
Q2 2023 | 53.01 | (23.8 %) | 0.54 | - | 53.01 | 0.54 |
Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS Before XO Items |
---|---|---|---|---|---|---|
2013 | 136.63 | 2.5 % | 1.52 | - | 136.63 | 1.52 |
2014 | 147.12 | 7.7 % | 1.63 | - | 147.12 | 1.63 |
2015 | 165.06 | 12.2 % | 1.83 | 13.75 | 151.31 | 1.68 |
2016 | 224.71 | 36.1 % | 2.50 | (1.68) | 226.39 | 2.52 |
2017 | 294.98 | 31.3 % | 3.28 | (11.69) | 306.67 | 3.41 |
2018 | 141.76 | (51.9 %) | 1.58 | - | 141.76 | 1.58 |
2019 | 146.92 | 3.6 % | 1.63 | 13.39 | 133.53 | 1.48 |
2020 | 132.00 | (10.2 %) | 1.47 | 51.23 | 80.76 | 0.90 |
2021 | 258.60 | 95.9 % | 2.87 | 10.35 | 248.26 | 2.76 |
2022 | 274.46 | 6.1 % | 3.05 | - | 274.46 | 3.05 |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
Q1 2014 | 42.75 % | 23.14 % | 17.85 % |
Q2 2014 | 42.69 % | 22.94 % | 18.48 % |
Q3 2014 | 42.42 % | 22.43 % | 17.92 % |
Q4 2014 | 41.90 % | 22.11 % | 17.11 % |
2014 | 41.76 % | 22.14 % | 17.13 % |
Q1 2015 | 41.98 % | 21.38 % | 15.76 % |
Q2 2015 | 41.58 % | 21.72 % | 15.48 % |
Q3 2015 | 41.54 % | 21.77 % | 15.49 % |
Q4 2015 | 41.35 % | 21.81 % | 15.34 % |
2015 | 41.32 % | 22.03 % | 15.35 % |
Q1 2016 | 42.51 % | 23.29 % | 17.20 % |
Q2 2016 | 43.49 % | 24.24 % | 18.50 % |
Q3 2016 | 44.66 % | 25.57 % | 19.88 % |
Q4 2016 | 46.07 % | 24.94 % | 19.47 % |
2016 | 46.07 % | 24.94 % | 19.47 % |
Q1 2017 | 46.32 % | 26.38 % | 21.29 % |
Q2 2017 | 46.38 % | 27.68 % | 22.38 % |
Q3 2017 | 46.73 % | 29.19 % | 24.08 % |
Q4 2017 | 46.13 % | 30.34 % | 25.30 % |
2017 | 46.13 % | 30.34 % | 25.30 % |
Q1 2018 | 44.93 % | 28.26 % | 22.97 % |
Q2 2018 | 42.33 % | 24.50 % | 18.99 % |
Q3 2018 | 39.86 % | 21.41 % | 15.49 % |
Q4 2018 | 36.95 % | 18.60 % | 12.00 % |
2018 | 36.95 % | 18.60 % | 12.00 % |
Q1 2019 | 35.60 % | 17.66 % | 9.96 % |
Q2 2019 | 35.23 % | 17.77 % | 9.57 % |
Q3 2019 | 35.16 % | 17.58 % | 8.93 % |
Q4 2019 | 35.77 % | 19.73 % | 10.66 % |
2019 | 35.77 % | 19.73 % | 10.66 % |
Q1 2020 | 34.79 % | 18.58 % | 9.44 % |
Q2 2020 | 33.85 % | 18.13 % | 9.05 % |
Q3 2020 | 34.50 % | 19.13 % | 9.55 % |
Q4 2020 | 34.12 % | 16.71 % | 6.13 % |
2020 | 34.12 % | 16.71 % | 6.13 % |
Q1 2021 | 34.76 % | 18.09 % | 7.62 % |
Q2 2021 | 35.67 % | 19.32 % | 8.88 % |
Q3 2021 | 35.20 % | 18.83 % | 8.64 % |
Q4 2021 | 36.12 % | 21.04 % | 11.79 % |
2021 | 36.12 % | 21.04 % | 11.79 % |
Q1 2022 | 36.72 % | 21.66 % | 12.54 % |
Q2 2022 | 37.15 % | 22.13 % | 12.98 % |
Q3 2022 | 37.06 % | 22.17 % | 12.42 % |
Q4 2022 | 35.98 % | 20.37 % | 11.03 % |
2022 | 35.98 % | 20.37 % | 11.03 % |
Q1 2023 | 35.84 % | 20.47 % | 11.04 % |
Q2 2023 | 35.54 % | 19.47 % | 10.07 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
2013 | 43.68 % | 23.16 % | 18.23 % |
2014 | 41.76 % | 22.14 % | 17.13 % |
2015 | 41.32 % | 22.03 % | 15.35 % |
2016 | 46.07 % | 24.94 % | 19.47 % |
2017 | 46.13 % | 30.34 % | 25.30 % |
2018 | 36.95 % | 18.60 % | 12.00 % |
2019 | 35.77 % | 19.73 % | 10.66 % |
2020 | 34.12 % | 16.71 % | 6.13 % |
2021 | 36.12 % | 21.04 % | 11.79 % |
2022 | 35.98 % | 20.37 % | 11.03 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
Q1 2014 | 42.20 % | 24.47 % | 19.51 % |
Q2 2014 | 42.73 % | 20.38 % | 15.64 % |
Q3 2014 | 39.09 % | 16.97 % | 11.38 % |
Q4 2014 | 43.13 % | 25.78 % | 20.97 % |
Q1 2015 | 42.48 % | 21.43 % | 14.17 % |
Q2 2015 | 41.14 % | 21.75 % | 14.62 % |
Q3 2015 | 39.26 % | 17.88 % | 11.96 % |
Q4 2015 | 42.25 % | 25.38 % | 19.75 % |
Q1 2016 | 46.50 % | 26.86 % | 21.08 % |
Q2 2016 | 45.01 % | 25.49 % | 19.84 % |
Q3 2016 | 44.80 % | 24.50 % | 18.81 % |
Q4 2016 | 47.75 % | 23.08 % | 18.25 % |
Q1 2017 | 47.43 % | 32.36 % | 28.09 % |
Q2 2017 | 45.27 % | 30.84 % | 24.28 % |
Q3 2017 | 46.32 % | 30.89 % | 26.02 % |
Q4 2017 | 45.49 % | 27.52 % | 22.96 % |
Q1 2018 | 42.69 % | 24.11 % | 18.82 % |
Q2 2018 | 33.82 % | 14.42 % | 6.86 % |
Q3 2018 | 36.08 % | 18.15 % | 11.56 % |
Q4 2018 | 34.83 % | 17.24 % | 10.20 % |
Q1 2019 | 37.45 % | 20.42 % | 10.95 % |
Q2 2019 | 32.33 % | 15.01 % | 5.37 % |
Q3 2019 | 35.77 % | 17.35 % | 8.83 % |
Q4 2019 | 37.06 % | 25.11 % | 16.42 % |
Q1 2020 | 33.62 % | 15.88 % | 6.12 % |
Q2 2020 | 27.38 % | 12.22 % | 2.82 % |
Q3 2020 | 37.81 % | 21.04 % | 10.67 % |
Q4 2020 | 35.42 % | 16.33 % | 4.22 % |
Q1 2021 | 35.75 % | 20.37 % | 10.64 % |
Q2 2021 | 34.26 % | 19.51 % | 9.69 % |
Q3 2021 | 35.37 % | 18.67 % | 9.16 % |
Q4 2021 | 38.73 % | 25.18 % | 17.07 % |
Q1 2022 | 38.02 % | 22.74 % | 13.56 % |
Q2 2022 | 36.34 % | 21.69 % | 11.91 % |
Q3 2022 | 35.19 % | 19.15 % | 7.30 % |
Q4 2022 | 34.56 % | 18.22 % | 11.30 % |
Q1 2023 | 37.23 % | 22.77 % | 13.21 % |
Q2 2023 | 35.06 % | 17.54 % | 7.91 % |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
Q1 2014 | 90.00 | 1.53 | 1.53 | 13.75 |
Q2 2014 | 90.00 | 1.65 | 1.65 | 13.36 |
Q3 2014 | 90.00 | 1.65 | 1.65 | 13.65 |
Q4 2014 | 90.00 | 1.63 | 1.63 | 14.15 |
Q1 2015 | 90.00 | 1.72 | 1.56 | 14.74 |
Q2 2015 | 90.00 | 1.73 | 1.58 | 14.63 |
Q3 2015 | 90.00 | 1.79 | 1.63 | 14.86 |
Q4 2015 | 90.00 | 1.83 | 1.68 | 15.48 |
Q1 2016 | 90.00 | 1.95 | 1.97 | 16.15 |
Q2 2016 | 90.00 | 2.15 | 2.21 | 15.76 |
Q3 2016 | 90.00 | 2.53 | 2.48 | 16.26 |
Q4 2016 | 90.00 | 2.50 | 2.52 | 16.85 |
Q1 2017 | 90.00 | 2.80 | 2.79 | 17.78 |
Q2 2017 | 90.00 | 2.97 | 2.93 | 17.24 |
Q3 2017 | 90.00 | 3.15 | 3.22 | 18.05 |
Q4 2017 | 90.00 | 3.28 | 3.41 | 18.80 |
Q1 2018 | 90.00 | 2.98 | 3.11 | 19.41 |
Q2 2018 | 90.00 | 2.41 | 2.54 | 17.98 |
Q3 2018 | 90.00 | 1.92 | 2.05 | 18.34 |
Q4 2018 | 90.00 | 1.58 | 1.58 | 17.79 |
Q1 2019 | 90.00 | 1.32 | 1.32 | 18.07 |
Q2 2019 | 90.00 | 1.28 | 1.28 | 16.24 |
Q3 2019 | 90.00 | 1.22 | 1.22 | 16.54 |
Q4 2019 | 90.00 | 1.63 | 1.48 | 16.91 |
Q1 2020 | 90.00 | 1.46 | 1.31 | 16.57 |
Q2 2020 | 90.00 | 1.36 | 1.21 | 16.65 |
Q3 2020 | 90.00 | 1.66 | 1.33 | 17.25 |
Q4 2020 | 90.00 | 1.47 | 0.90 | 19.94 |
Q1 2021 | 90.00 | 1.84 | 1.27 | 19.89 |
Q2 2021 | 90.00 | 2.29 | 1.72 | 20.42 |
Q3 2021 | 90.00 | 2.24 | 1.86 | 20.86 |
Q4 2021 | 90.00 | 2.87 | 2.76 | 20.74 |
Q1 2022 | 90.00 | 3.21 | 3.09 | 21.70 |
Q2 2022 | 90.00 | 3.45 | 3.34 | 22.47 |
Q3 2022 | 90.00 | 3.38 | 3.27 | 21.96 |
Q4 2022 | 90.00 | 3.05 | 3.05 | 22.11 |
Q1 2023 | 97.68 | 2.93 | 2.93 | 32.03 |
Q2 2023 | 97.68 | 2.76 | 2.76 | 32.07 |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
2013 | 90.00 | 1.52 | 1.52 | 13.22 |
2014 | 90.00 | 1.63 | 1.63 | 14.15 |
2015 | 90.00 | 1.83 | 1.68 | 15.48 |
2016 | 90.00 | 2.50 | 2.52 | 16.85 |
2017 | 90.00 | 3.28 | 3.41 | 18.80 |
2018 | 90.00 | 1.58 | 1.58 | 17.79 |
2019 | 90.00 | 1.63 | 1.48 | 16.91 |
2020 | 90.00 | 1.47 | 0.90 | 19.94 |
2021 | 90.00 | 2.87 | 2.76 | 20.74 |
2022 | 90.00 | 3.05 | 3.05 | 22.11 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
Q1 2014 | 33.02 | 33.02 | 3.69 |
Q2 2014 | 33.91 | 33.91 | 4.19 |
Q3 2014 | 43.67 | 43.67 | 5.29 |
Q4 2014 | 45.25 | 45.25 | 5.23 |
Q1 2015 | 40.15 | 44.08 | 4.67 |
Q2 2015 | 45.84 | 50.27 | 5.43 |
Q3 2015 | 32.29 | 35.31 | 3.88 |
Q4 2015 | 27.26 | 29.73 | 3.23 |
Q1 2016 | 27.46 | 27.14 | 3.31 |
Q2 2016 | 28.54 | 27.81 | 3.89 |
Q3 2016 | 21.29 | 21.71 | 3.31 |
Q4 2016 | 27.05 | 26.85 | 4.01 |
Q1 2017 | 25.95 | 25.99 | 4.08 |
Q2 2017 | 26.81 | 27.16 | 4.62 |
Q3 2017 | 24.63 | 24.12 | 4.30 |
Q4 2017 | 21.93 | 21.10 | 3.82 |
Q1 2018 | 24.80 | 23.77 | 3.80 |
Q2 2018 | 28.42 | 26.97 | 3.81 |
Q3 2018 | 22.92 | 21.46 | 2.39 |
Q4 2018 | 25.39 | 25.39 | 2.25 |
Q1 2019 | 32.81 | 32.81 | 2.40 |
Q2 2019 | 34.90 | 34.90 | 2.76 |
Q3 2019 | 36.10 | 36.10 | 2.66 |
Q4 2019 | 25.93 | 28.53 | 2.50 |
Q1 2020 | 28.43 | 31.66 | 2.50 |
Q2 2020 | 31.13 | 34.94 | 2.55 |
Q3 2020 | 30.78 | 38.40 | 2.97 |
Q4 2020 | 35.71 | 58.36 | 2.63 |
Q1 2021 | 31.13 | 45.10 | 2.88 |
Q2 2021 | 37.67 | 50.14 | 4.22 |
Q3 2021 | 34.24 | 41.38 | 3.68 |
Q4 2021 | 28.37 | 29.55 | 3.93 |
Q1 2022 | 34.32 | 35.59 | 5.07 |
Q2 2022 | 34.85 | 36.05 | 5.35 |
Q3 2022 | 50.66 | 52.45 | 7.81 |
Q4 2022 | 52.67 | 52.67 | 7.27 |
Q1 2023 | 52.51 | 52.51 | 4.81 |
Q2 2023 | 60.71 | 60.71 | 5.23 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
2013 | 26.15 | 26.15 | 3.00 |
2014 | 45.25 | 45.25 | 5.23 |
2015 | 27.26 | 29.73 | 3.23 |
2016 | 27.05 | 26.85 | 4.01 |
2017 | 21.93 | 21.10 | 3.82 |
2018 | 25.39 | 25.39 | 2.25 |
2019 | 25.93 | 28.53 | 2.50 |
2020 | 35.71 | 58.36 | 2.63 |
2021 | 28.37 | 29.55 | 3.93 |
2022 | 52.67 | 52.67 | 7.27 |
Q2 2023
2023
Period | Medical Services | Medicine and Pharmaceutical Products |
---|---|---|
Q1 2014 | 195.44 | 12.12 |
Q2 2014 | 201.76 | 17.69 |
Q3 2014 | 177.26 | 15.52 |
Q4 2014 | 223.36 | 16.72 |
Q1 2015 | 224.02 | 16.38 |
Q2 2015 | 228.38 | 16.85 |
Q3 2015 | 215.41 | 8.52 |
Q4 2015 | 257.40 | 18.49 |
Q1 2016 | 276.15 | 8.88 |
Q2 2016 | 277.42 | 10.93 |
Q3 2016 | 265.04 | 8.13 |
Q4 2016 | 307.51 | 8.73 |
Q1 2017 | 239.94 | 62.81 |
Q2 2017 | 229.31 | 58.90 |
Q3 2017 | 235.08 | 60.17 |
Q4 2017 | 241.44 | 84.43 |
Q1 2018 | 236.76 | 71.84 |
Q2 2018 | 205.73 | 67.39 |
Q3 2018 | 218.43 | 62.50 |
Q4 2018 | 228.74 | 89.55 |
Q1 2019 | 239.22 | 81.93 |
Q2 2019 | 210.95 | 75.06 |
Q3 2019 | 232.55 | 68.79 |
Q4 2019 | 259.40 | 84.20 |
Q1 2020 | 227.83 | 86.77 |
Q2 2020 | 166.96 | 80.60 |
Q3 2020 | 260.50 | 90.30 |
Q4 2020 | 309.74 | 95.55 |
Q1 2021 | 378.70 | 115.97 |
Q2 2021 | 374.54 | 116.29 |
Q3 2021 | 412.23 | 131.88 |
Q4 2021 | 472.23 | 103.34 |
Q1 2022 | 470.53 | 138.87 |
Q2 2022 | 475.30 | 108.52 |
Q3 2022 | 438.86 | 162.03 |
Q4 2022 | 547.10 | 146.77 |
Q1 2023 | 530.59 | 186.05 |
Q2 2023 | 513.01 | 157.40 |
Period | Medical Services | Medicine and Pharmaceutical Products |
---|---|---|
2013 | 689.17 | 60.48 |
2014 | 797.83 | 62.05 |
2015 | 925.20 | 60.24 |
2016 | 1,126.12 | 36.67 |
2017 | 945.78 | 266.30 |
2018 | 889.66 | 291.28 |
2019 | 942.12 | 309.97 |
2020 | 965.03 | 353.22 |
2021 | 1,637.71 | 467.47 |
2022 | 1,931.79 | 556.20 |
Item | Q2 2023 (e) | Q2 2023 (a) | Change |
---|---|---|---|
Average | 81.24 | 53.01 | (34.8 %) |
Item | Q2 2023 (e) | Q2 2023 (a) | Change |
---|---|---|---|
Goldman Sachs | 66.42 | 53.01 | (20.2) % |
Al Rajhi Capital | 73.00 | 53.01 | (27.4) % |
U-Capital | 75.50 | 53.01 | (29.8) % |
OSOOL AND BAKHEET | 79.70 | 53.01 | (33.5) % |
AlJazira Capital | 85.20 | 53.01 | (37.8) % |
Hermes | 86.00 | 53.01 | (38.4) % |
SNB Capital | 91.10 | 53.01 | (41.8) % |
HSBC | 93.00 | 53.01 | (43.0) % |
Current | |
Market Cap (M Riyal) | 15,921.84 |
Enterprise Value (EV) (M) | 17,841.44 |
Shares Outstanding ((M)) | 97.68 |
EPS ( Riyal) (TTM) | 4.54 |
Book Value (BV) ( Riyal) | 34.51 |
Par Value ( Riyal) | 10.00 |
Adjusted P/E (Last12) | 35.89 |
P/E (TTM) | 35.89 |
Price/book | 4.72 |
Return on Average Assets (%) (TTM) | 7.1 |
Return on Average Equity (%) (TTM) | 13.6 |
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}